EDWARDS LIFESCIENCES REPORTS THIRD QUARTER RESULTS

Go back to EDWARDS LIFESCIENCES REPORTS THIRD QUARTER RESULTS

Edwards Lifesciences (EW) tumbles as guidance misses expectations

October 26, 2023 10:07 AM UTC

Edwards Lifesciences (NYSE: EW) shares tumbled over 8% in after-hours trading after the company's latest earnings and guidance announcement disappointed investors and analysts alike.

After Wednesday's close, the company reported Q3 earnings of $0.59 per share, in line with the analyst estimate of $0.59. Revenue for the quarter was also in line, coming in at $1.48 billion, although that was a 12%... More

Edwards Lifesciences (EW) Reports In-Line Q3 EPS

October 25, 2023 4:16 PM UTC

Edwards Lifesciences (NYSE: EW) reported Q3 EPS of $0.59, in-line with the analyst estimate of $0.59. Revenue for the quarter came in at $1.48 billion versus the consensus estimate of $1.48 billion.

GUIDANCE:

Edwards Lifesciences sees Q4 2023 revenue of $1.45-1.53 billion, versus the consensus of... More